1. Product Specifications & Comparative Analysis

Molecular Formula: C₁₄H₁₈N₂O
Molecular Weight: 230.31 g/mol

2. Applications & Pharmacological Properties

Ibudilast is a cyclic nucleotide phosphodiesterase (PDE) inhibitor with demonstrated:

• Anti-asthmatic effects through tracheal smooth muscle relaxation
• Antiplatelet aggregation activity (IC₅₀ = 8.3 μM)
• Neuroprotective properties against microglia-mediated neurotoxicity
• Potential therapeutic applications in dementia and multiple sclerosis

3. Research Use Cases

Pharmaceutical Development

• Preclinical studies for neuroinflammatory disorders
• Formulation optimization of sustained-release tablets

Academic Research

• Mechanistic studies on PDE4/10 inhibition pathways
• In vivo models of chronic obstructive pulmonary disease

4. Client Success Stories

Case 1: Shanghai Biomedical Institute

Utilized 500g batch (Hubei Widely) for longitudinal neuroprotection studies, achieving 92% experimental reproducibility.

Case 2: European Pharma Contract Lab

Sourced 10kg through Zouping Mingyuan for GMP-compliant API synthesis, reducing lead time by 40%.

Case 3: US Research Consortium

Partnered with Meryer for analytical reference standards, enabling FDA preclinical documentation.

5. Inquiry & Ordering

Global Procurement Options:
Email: info@vivalr.com
Phone: (86) 15866781826

Request bulk pricing, COA documentation, or custom synthesis proposals.
Note: For research use only. Not for human diagnostic/therapeutic applications.